Drugs giant Novartis posts $2.08 billion Q4 net profit

Drugs giant Novartis posts $2.08 billion Q4 net profit

PanARMENIAN.Net - Swiss drug maker Novartis AG has reported a fourth-quarter net profit of $2.08 billion, AP said.

The result is 72 percent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million after ending its clinical study into wider uses of the hypertension drug Tekturna.

Novartis said Wednesday, January 23 that fourth-quarter sales in 2012 were almost flat at $14.83 billion compared with $14.78 billion in the same period the previous year.

The company also said that long-time chairman and former chief executive Daniel Vasella will leave the board at the next shareholders' meeting at the end of February.

 Top stories
This year’s event will be held in Yerevan under the motto “16 Countries … and Opportunities for Enterprise Development.”
“Government’s policy line of boosting the NPP’s safety and building a new power unit remains unchanged,” Armen Movsisyan said.
Armenia’s rich cultural, historical and Christian heritage will be presented in travel guides and maps in Russian during the exhibition.
The contract terms stipulated by companies allowed them to charge subscribers for the period when no internet service was provided.
Partner news